THOMAS A BUCHHOLZ to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Randomized Controlled Trials as Topic.
Connection Strength
0.738
-
Accelerated partial breast irradiation: Current status with a focus on clinical practice. Breast J. 2019 01; 25(1):124-128.
Score: 0.093
-
A clinical perspective on regional nodal irradiation for breast cancer. Breast. 2017 Aug; 34 Suppl 1:S85-S90.
Score: 0.084
-
Surgical Considerations After Neoadjuvant Chemotherapy: Breast Conservation Therapy. J Natl Cancer Inst Monogr. 2015 May; 2015(51):11-4.
Score: 0.073
-
Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy. Lancet Oncol. 2012 Jun; 13(6):e270-6.
Score: 0.059
-
The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol. 2011 Jan; 21(1):26-34.
Score: 0.054
-
Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast. J Surg Oncol. 2007 Jun 15; 95(8):610-3.
Score: 0.042
-
Accelerated partial breast irradiation. Curr Probl Cancer. 2007 Jan-Feb; 31(1):7-25.
Score: 0.041
-
Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy. Cancer. 2005 Aug 15; 104(4):676-81.
Score: 0.037
-
Inflammatory breast cancer: current concepts in local management. Breast Dis. 2005-2006; 22:75-83.
Score: 0.035
-
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):336-44.
Score: 0.032
-
Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer. 2003 Sep 15; 98(6):1150-60.
Score: 0.032
-
Radiotherapy for early stage favourable breast cancers. Br J Cancer. 2002 Jan 21; 86(2):309-11.
Score: 0.029
-
Controversies regarding the use of radiation after mastectomy in breast cancer. Oncologist. 2002; 7(6):539-46.
Score: 0.029
-
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2019 02 10; 37(5):423-438.
Score: 0.023
-
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression. J Clin Oncol. 2016 05 10; 34(14):1689-701.
Score: 0.019
-
Radiation field design in the ACOSOG Z0011 (Alliance) Trial. J Clin Oncol. 2014 Nov 10; 32(32):3600-6.
Score: 0.017
-
Evaluating locoregional recurrence in breast cancer. Int J Radiat Oncol Biol Phys. 2003 Mar 01; 55(3):850-1; author reply 851.
Score: 0.016
-
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol. 2010 Aug 10; 28(23):3784-96.
Score: 0.013
-
Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005 Mar 16; 97(6):419-24.
Score: 0.009